BMK-101
Ovarian and Triple‑Negative Breast Cancer
PreclinicalActive
Key Facts
About Biomakers
Argentinian biotech Biomakers develops engineered biologics for oncology and immunology using a proprietary protein‑engineering platform.
View full company profile